Sivelestat sodium for treatment of patients with COVID-19-associated acute respiratory distress syndrome in intensive care unit: a single-center retrospective cohort study

CONCLUSION: Sivelestat sodium treatment is not correlated with the reduction of mortality or length of hospital stay, but is associated with reduced serum IL-6 level in patients with COVID-19-associated ARDS.PMID:37712261 | DOI:10.12122/j.issn.1673-4254.2023.08.01
Source: Journal of Southern Medical University - Category: Universities & Medical Training Authors: Source Type: research